Bruce D. Jackson
Stock Analyst at Benchmark
(2.89)
# 1,705
Out of 5,063 analysts
8
Total ratings
71.43%
Success rate
21.79%
Average return
Main Sectors:
Stocks Rated by Bruce D. Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLSS Milestone Scientific | Maintains: Speculative Buy | $1.25 → $1 | $0.31 | +227.12% | 1 | Nov 20, 2025 | |
| HUMA Humacyte | Maintains: Buy | $14 → $11 | $1.12 | +882.14% | 1 | Nov 13, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $60 → $75 | $100.67 | -25.50% | 1 | Nov 4, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $80 → $132 | $109.18 | +20.90% | 1 | Oct 31, 2025 | |
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Speculative Buy | $14 → $7 | $0.48 | +1,358.33% | 1 | Sep 15, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Speculative Buy | $3 → $21 | $5.27 | +298.48% | 1 | Sep 15, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $3 → $2 | $0.56 | +256.06% | 1 | Sep 10, 2025 | |
| CLNN Clene | Maintains: Buy | $33 → $31 | $8.76 | +253.88% | 1 | Sep 10, 2025 |
Milestone Scientific
Nov 20, 2025
Maintains: Speculative Buy
Price Target: $1.25 → $1
Current: $0.31
Upside: +227.12%
Humacyte
Nov 13, 2025
Maintains: Buy
Price Target: $14 → $11
Current: $1.12
Upside: +882.14%
Exact Sciences
Nov 4, 2025
Maintains: Buy
Price Target: $60 → $75
Current: $100.67
Upside: -25.50%
Belite Bio
Oct 31, 2025
Maintains: Buy
Price Target: $80 → $132
Current: $109.18
Upside: +20.90%
Reviva Pharmaceuticals Holdings
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $14 → $7
Current: $0.48
Upside: +1,358.33%
Unicycive Therapeutics
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $3 → $21
Current: $5.27
Upside: +298.48%
Harvard Bioscience
Sep 10, 2025
Maintains: Speculative Buy
Price Target: $3 → $2
Current: $0.56
Upside: +256.06%
Clene
Sep 10, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $8.76
Upside: +253.88%